Sandra E. Peterson
Operating Partner, Clayton, Dubilier & Rice (CD&R)
Ms. Peterson is an Operating Partner at Clayton, Dubilier & Rice (CD&R), where she spans consumer and healthcare investing and spearheads the firm’s technology and AI capabilities to support its investments and portfolio companies. She is the Lead Independent Director of the Microsoft Board of Directors.
Prior to joining CD&R, she was Group Worldwide Chairman of Johnson & Johnson, where her portfolio included medical devices, consumer, global operating infrastructure, technology, supply chain, and key strategic initiatives. Previously, she served as Chairman and CEO of Bayer CropScience AG, CEO of Bayer Medical Care, and President of Bayer HealthCare AG’s Diabetes Care Division. She began her career at McKinsey and later held executive positions at Medco Health Solutions (formerly Merck-Medco), Nabisco, and Whirlpool.
Ms. Peterson is Executive Chairman of Volastra and serves on the boards of Zephyr AI and Seaport Therapeutics. She is also Chairman of the Board of the American Academy in Berlin, serves on the international advisory board of Hakluyt & Company and Temasek, and is an Executive Committee Trustee of the Institute for Advanced Study.
She has appeared on FORTUNE magazine’s Most Powerful Women list numerous times and was featured on the Magazine’s inaugural list of Leaders Who Are Changing Healthcare. She attended Princeton University (M.P.A., Applied Economics), and Cornell University (B.A., Government).